Skip to content
← Research Hub
MetabolismPEM-relevant

Energy Metabolism

206 studies in the atlas

Altered energy metabolism is a candidate mechanism under active investigation in ME/CFS research. Studies report signals suggestive of impaired cellular energy production, altered metabolomics profiles, and elevated oxidative stress markers in patient populations. Metabolomics analyses have identified differences in metabolites associated with the citric acid cycle and amino acid metabolism, though findings are not uniform across cohorts and a specific mitochondrial mechanism has not been established. Cellular energy stress may contribute to the reduced functional capacity seen in ME/CFS; direct mechanistic proof for post-exertional malaise has not been demonstrated.

What we know

  • Naviaux et al. (2016) identified a hypometabolic state in ME/CFS patients using broad metabolomic profiling
  • Multiple independent studies have reported altered metabolite levels, though specific findings vary across cohorts
  • Signals suggestive of impaired cellular energy production have been reported, including reduced oxidative phosphorylation in some studies, but a specific mitochondrial mechanism has not been established
  • Metabolic differences appear to worsen after exertion in several studies, a pattern consistent with PEM

What remains uncertain

  • Whether altered energy metabolism is a primary cause or a consequence of upstream immune or neurological processes
  • Mitochondrial impairment has been proposed and partially supported, but the evidence is heterogeneous and a specific mechanism has not been established
  • The relationship between metabolic findings and specific symptoms is not well mapped
  • Whether metabolic subtypes exist that respond to different interventions

What is emerging

  • Whether metabolomic profiles can serve as diagnostic biomarkers
  • Whether targeted metabolic interventions (e.g., oxaloacetate, NAD+ precursors) have measurable benefit
  • The full extent of metabolic overlap between ME/CFS and Long COVID
  • How metabolic impairment relates to the exercise intolerance demonstrated in CPET studies

Start here

E0 ConsensusPEM required

Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis.

Jinushi, Ryuhei, Masuda, Sakue, Tanisaka, Yuki et al.·Journal of translational medicine·2023

This review combined results from seven studies comparing a chemical in the blood called acylcarnitine between people with ME/CFS and healthy people. Researchers found that people with ME/CFS have significantly lower levels of this chemical. These lower levels might one day help doctors diagnose ME/CFS, though more research is needed before it can be used as a reliable test.

Research Momentum

203 publications over 36 years. Recent trend: steady (14/year over the last 3 years).

Top Studies

60 of 206, sorted by evidence level and year

E0ReviewPEM ✓

Insights into the Complex Biological Network Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

2025
Dudova, Dobrina et al.·International journal of molecular sciences·Review-Narrative
E0ReviewPEM ?

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease.

2024
Arron, Hayley E et al.·Frontiers in immunology·Review-Narrative
E0ReviewPEM ✓

Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis.

2023
Jinushi, Ryuhei et al.·Journal of translational medicine·Systematic-Review
E0ReviewPEM ✗

Coenzyme Q10: Clinical Applications beyond Cardiovascular Diseases.

2021
Testai, Lara et al.·Nutrients·Review-Narrative
E0ReviewPEM ?

A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome.

2021
Maksoud, Rebekah et al.·Journal of translational medicine·Systematic-Review
E0ReviewPEM ✓

[Myalgic encephalomyelitis or chronic fatigue syndrome].

2019
Brinth, Louise et al.·Ugeskrift for laeger·Review-Narrative
E0ReviewPEM ✗

Myalgic encephalomyelitis/chronic fatigue syndrome: From pathophysiological insights to novel therapeutic opportunities.

2019
Morris, Gerwyn et al.·Pharmacological research·Review-Narrative
E0ReviewPEM ?

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease.

2018
Sotzny, Franziska et al.·Autoimmunity reviews·Review-Narrative
E0ReviewPEM ?

Chronic fatigue syndrome: a personalized integrative medicine approach.

2014
Brown, Benjamin I·Alternative therapies in health and medicine·Review-Narrative
E0ReviewPEM ?

Metabolic reprogramming in diabetes and other endocrine and metabolic disorders: exploring the Warburg effect, ketones, and SGLT2 inhibitors.

2026
Carrera-Bastos, Pedro et al.·Reviews in endocrine & metabolic disorders·Review-Narrative
E0ReviewPEM ?

Pathophysiological mechanisms of post-exertional malaise: an integrative analysis based on the metabolism-immune-neuro interaction model.

2026
Jin, Hongjiao et al.·Frontiers in immunology·Systematic-Review
E0ReviewPEM ✗

Understanding the kynurenine pathway: A narrative review on its impact across chronic pain conditions.

2024
Hazrati, Ebrahim et al.·Molecular pain·Review-Narrative
E0ReviewPEM ?

Induced pluripotent stem cells as suitable sensors for fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome.

2021
Monzón-Nomdedeu, María B et al.·World journal of stem cells·Review-Narrative
E0ReviewPEM ?

Diagnostic and Pharmacological Potency of Creatine in Post-Viral Fatigue Syndrome.

2021
Ostojic, Sergej M·Nutrients·Review-Narrative
E0ReviewPEM ?

Recent Perspectives on the Physiological and Therapeutic Benefits of Placental Extracts in Chronic Noninfectious Diseases and Aging.

2026
Xinliang, Zhang et al.·Current medicinal chemistry·Systematic-Review
E0ReviewPEM ?

Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and D-lactic acidosis: a systematic review.

2017
Wallis, Amy et al.·Journal of translational medicine·Systematic-Review
E0ReviewPEM ✗

Pesticides and human chronic diseases: evidences, mechanisms, and perspectives.

2013
Mostafalou, Sara et al.·Toxicology and applied pharmacology·Review-Narrative
E1TrialPEM ?

RESTORE ME: a RCT of oxaloacetate for improving fatigue in patients with myalgic encephalomyelitis/chronic fatigue syndrome.

2024
Cash, Alan et al.·Frontiers in neurology·RCT
E1CohortPEM ✓

Metabolic features of chronic fatigue syndrome

2016 · n=84
Robert K. Naviaux et al.·Proceedings of the National Academy of Sciences (PNAS)·Observational
E1TrialPEM ✗

Supplementation with Guanidinoacetic Acid in Women with Chronic Fatigue Syndrome.

2016
Ostojic, Sergej M et al.·Nutrients·RCT
E1TrialPEM ✗

Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome?

2015
Castro-Marrero, Jesús et al.·Antioxidants & redox signaling·RCT
E1TrialPEM ✗

Amantadine and L-carnitine treatment of Chronic Fatigue Syndrome.

1997
Plioplys, A V et al.·Neuropsychobiology·RCT
E1TrialPEM ?

Chronic fatigue syndrome and chronic primary magnesium deficiency (CFS and CPMD).

1992
Durlach, J·Magnesium research·RCT
E2CohortPEM ?

AI-driven multi-omics modeling of myalgic encephalomyelitis/chronic fatigue syndrome.

2025
Xiong, Ruoyun et al.·Nature medicine·Longitudinal
E2CohortPEM ?

Circulating Levels of SMPDL3B Define Metabolic Endophenotypes and Subclinical Kidney Alterations in Myalgic Encephalomyelitis.

2025
Rostami-Afshari, Bita et al.·International journal of molecular sciences·Cross-Sectional
E2CohortPEM ✗

Alterations in gut microbiota and associated metabolites in patients with chronic fatigue syndrome.

2025
Cheng, Xinxin et al.·Scientific reports·Case-Control
E2CohortPEM ?

Leveraging Explainable Automated Machine Learning (AutoML) and Metabolomics for Robust Diagnosis and Pathophysiological Insights in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

2025
Yagin, Fatma Hilal et al.·Diagnostics (Basel, Switzerland)·Cross-Sectional
E2CohortPEM ?

Untargeted Metabolomics and Quantitative Analysis of Tryptophan Metabolites in Myalgic Encephalomyelitis Patients and Healthy Volunteers: A Comparative Study Using High-Resolution Mass Spectrometry.

2024
Abujrais, Sandy et al.·ACS chemical neuroscience·Cross-Sectional
E2CohortPEM ✗

Association between fatigue, peripheral serotonin, and L-carnitine in hypothyroidism and in chronic fatigue syndrome.

2024
Raij, Tommi et al.·Frontiers in endocrinology·Observational
E2MechanismPEM ✓

Plasma metabolomics reveals disrupted response and recovery following maximal exercise in myalgic encephalomyelitis/chronic fatigue syndrome.

2022
Germain, Arnaud et al.·JCI insight·Observational
E2CohortPEM ?

A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome.

2021
Hoel, Fredrik et al.·JCI insight·Cross-Sectional
E2CohortPEM ?

Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms.

2021
Nkiliza, Aurore et al.·Journal of translational medicine·Observational
E2CohortPEM ✗

Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Not Due to Anti-mitochondrial Antibodies.

2020
Nilsson, Isabell et al.·Frontiers in medicine·Cross-Sectional
E2CohortPEM ?

Deep phenotyping of myalgic encephalomyelitis/chronic fatigue syndrome in Japanese population.

2020
Kitami, Toshimori et al.·Scientific reports·Cross-Sectional
E2CohortPEM ?

Comprehensive Circulatory Metabolomics in ME/CFS Reveals Disrupted Metabolism of Acyl Lipids and Steroids.

2020
Germain, Arnaud et al.·Metabolites·Cross-Sectional
E2CohortPEM ?

Changes in DNA methylation profiles of myalgic encephalomyelitis/chronic fatigue syndrome patients reflect systemic dysfunctions.

2020
Helliwell, A M et al.·Clinical epigenetics·Case-Control
E2CohortPEM ✓

Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with Myalgic encephalomyelitis/Chronic fatigue syndrome.

2019
Ghali, Alaa et al.·Scientific reports·Cross-Sectional
E2CohortPEM ?

MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants.

2019
Venter, Marianne et al.·Scientific reports·Observational
E2CohortPEM ?

Low omega-3 index and polyunsaturated fatty acid status in patients with chronic fatigue syndrome/myalgic encephalomyelitis.

2018
Castro-Marrero, Jesús et al.·Prostaglandins, leukotrienes, and essential fatty acids·Cross-Sectional
E2CohortPEM ✗

Chronic fatigue syndrome patients have alterations in their oral microbiome composition and function.

2018
Wang, Taiwu et al.·PloS one·Cross-Sectional
E2CohortPEM ✗

Higher Prevalence of "Low T3 Syndrome" in Patients With Chronic Fatigue Syndrome: A Case-Control Study.

2018
Ruiz-Núñez, Begoña et al.·Frontiers in endocrinology·Case-Control
E2MechanismPEM ?

Evidence of mitochondrial dysfunction and impaired redox signalling in a subgroup of patients with myalgic encephalomyelitis/chronic fatigue syndrome

2017 · n=25
Cara Tomas et al.·The EPMA Journal·Mechanistic
E2CohortPEM ?

Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism.

2017
Germain, Arnaud et al.·Molecular bioSystems·Cross-Sectional
E2CohortPEM ?

Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.

2017
Nagy-Szakal, Dorottya et al.·Microbiome·Cross-Sectional
E2CohortPEM ✗

Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome.

2017
Schoeman, Elizna M et al.·BMC medical genetics·Cross-Sectional
E2CohortPEM ✗

Genetic evaluation of AMPD1, CPT2, and PGYM metabolic enzymes in patients with chronic fatigue syndrome.

2016
Maltese, P E et al.·Genetics and molecular research : GMR·Case-Control
E2CohortPEM ✗

Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles.

2016
Yamano, Emi et al.·Scientific reports·Cross-Sectional
E2CohortPEM ?

Mitochondrial DNA variants correlate with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome.

2016
Billing-Ross, Paul et al.·Journal of translational medicine·Case-Control
E2CohortPEM ?

Association of mitochondrial DNA variants with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) symptoms.

2016
Hanson, Maureen R et al.·Journal of translational medicine
E2CohortPEM ?

Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

2012
Booth, Norman E et al.·International journal of clinical and experimental medicine·Cross-Sectional
E2CohortPEM ✗

Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology.

2012
Shungu, Dikoma C et al.·NMR in biomedicine·Cross-Sectional
E2CohortPEM ✗

The assessment of the energy metabolism in patients with chronic fatigue syndrome by serum fluorescence emission.

2012
Mikirova, Nina et al.·Alternative therapies in health and medicine·Case-Control
E2CohortPEM ✗

Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome.

2011
Smits, Bart et al.·Mitochondrion·Cross-Sectional
E2CohortPEM ✗

Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I activity.

2011
Reuter, S E et al.·Journal of internal medicine·Cross-Sectional
E2CohortPEM ✗

Chronic fatigue syndrome is associated with metabolic syndrome: results from a case-control study in Georgia.

2010
Maloney, Elizabeth M et al.·Metabolism: clinical and experimental·Case-Control
E2CohortPEM ✗

Physiological cost of walking in those with chronic fatigue syndrome (CFS): a case-control study.

2009
Paul, Lorna et al.·Disability and rehabilitation·Case-Control
E2CohortPEM ✗

Increased d-lactic Acid intestinal bacteria in patients with chronic fatigue syndrome.

2009
Sheedy, John R et al.·In vivo (Athens, Greece)·Case-Control
E2CohortPEM ✗

Chronic fatigue syndrome and mitochondrial dysfunction.

2009
Myhill, Sarah et al.·International journal of clinical and experimental medicine·Cross-Sectional
E2CohortPEM ✗

Visible and near-infrared spectral changes in the thumb of patients with chronic fatigue syndrome.

2009
Sakudo, Akikazu et al.·Clinica chimica acta; international journal of clinical chemistry·Cross-Sectional
E2MechanismPEM ✗

Transcription profile analysis of vastus lateralis muscle from patients with chronic fatigue syndrome.

2009
Pietrangelo, T et al.·International journal of immunopathology and pharmacology·Mechanistic

Contribute

Private, reviewed by a human. Not a public comment thread.